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Theosteochondralhealingpotentialofhyaluronicacid(HA)plusdiacereinwasevaluatedinsubchondral-drilling-(SCD-)induced
ﬁbrocartilage generation in rabbits. A full-thickness chondral defect was created along the patellar groove of both knees and then
SCD was subsequently performed only in the left knee. A week later, the rabbits were allocated into 3 groups to receive weekly
intra-articular (IA) injection for 5 weeks with normal saline solution (NSS) (group 1) or with HA (group 2 and group 3). Starting
at the ﬁrst IA injection, rabbits were also gavaged daily for 9 weeks with NSS (group 1 and group 2) or with diacerein (group 3).
The animals were then sacriﬁced for evaluation. The newly formed tissue in SCD lesions showed signiﬁcantly better histological
grading scale and had higher content of type II collagen in HA-treated group compared to NSS control. In addition, adding oral
diacerein to HA injection enhanced healing potential of HA.
1.Introduction
Osteoarthritis (OA) is a degenerative disease that aﬀects syn-
ovial joints. Initial lesion can be focal and local, but extensive
articular cartilage breakdown can result, which may even
produce profound alterations of the subchondral bone. The
disease is slowly progressive and related with ageing and
weight bearing of the joint. Common locations of OA are the
knee and the hip, and pain is the most common presentation
aggravated by mechanical loading. In early stage of knee OA,
symptoms can be alleviated with analgesics, nonsteroidal
anti-inﬂammatory drugs (NSAIDs), and/or intra-articular
(IA) injection of hyaluronic acid (HA) [1, 2]. However, these
medications are less satisfactory in late-stage OA, for which
the treatment of choice is usually a replacement arthroplasty
[2]. However, for a smaller focal articular defect, diﬀerent
approaches are proposed to enhance cartilaginous healing
potential. Subchondral drilling (SCD) is one of the tech-
niques frequently used in this condition [3]. By drilling or
prickling with an awl, the subchondral bone plate within the
chondral defect is penetrated. The defect leads to bleeding
and subsequent ﬁbrin clot formation ﬁlling the defect and
covering the exposed bony surface. Bone-marrow-derived
stem cells then migrate into the clot and stimulate ﬁbrocar-
tilaginous repaired tissue. Compared to native hyaline car-
tilage, the regenerated ﬁbrocartilage is thinner and consists
mainly of type I collagen, which is less durable to loading
than normal hyaline cartilage, which contains mainly type II
collagen [4]. This is a signiﬁcant drawback of this procedure
besidesitsconstraintregardingthelimitedsizeofthesuitable
defect [3].
The inferior biochemical and biomechanical properties
of the ﬁbrocartilage in comparison to the normal articular
cartilage predispose to the development of degenerative
osteoarthritis [3]. Research is on going in an attempt to use
adjuvant treatments to improve the quality of the repaired
tissueafterthesurgicalprocedure,withthegoalofproducing
a more hyaline-like repair capable of stable and long-term2 The Scientiﬁc World Journal
function. In this experiment, we aim to study the eﬃcacy of
IAinjectionofHAafterSCDcomparablewiththemicrofrac-
ture technique for the treatment of articular cartilage lesions.
In addition, one of the symptomatic slow-acting drugs in
osteoarthritis(SYSADOA),diacerein,isaddedtoHAtherapy
to investigate its additive eﬀect compared to administration
of HA alone.
HA, a nonsulfated glycosaminoglycan, is a major com-
ponent found in the extracellular cartilaginous matrix and
in the synovial ﬂuid. This compound is generally produced
by chondrocytes, synoviocytes, and ﬁbroblasts. Aggregates
formed by HA and aggrecan absorb water molecules into
the articular cartilage rendering elasticity of this structure
and contribute to shock absorption property of the joint. It
not only works as a lubricant and a mechanical barrier but
alsohasanalgesic,anti-inﬂammatory,andchondroprotective
eﬀects [5, 6]. An anticatabolic eﬀect of HA has been demon-
s t r a t e di nb o t hi nv i t r oa n di nv i v om o d e l s[ 7, 8]. Intra-
articular injection of HA was shown to reduce articular
lesions of articular cartilage by inhibiting production of
interleukin-1β (IL-1β)[ 9], nitric oxide (NO) [10], and
metalloproteinases (MMPs) [9] leading to further decrease
of cartilaginous matrix degradation. HA also enhances
chondrocyte proliferation [11, 12] as well as increases syn-
thesis of the components of cartilage, such as sulfated gly-
cosaminoglycans,chondroitin-6-sulphate,proteoglycan,and
type II collagen [13], which subsequently increase hyaline-
like cartilage.
Diacerein (9,10-dihydro-4,5-bis(acetyloxy)9,10-dioxo-2-
anthracene carboxylic acid) is one of SYSADOA for the
treatment of OA [16]. After oral administration, it is rapidly
broken down and deacetylated into its active metabolite,
rhein [17]. The potential disease-modifying properties of
diacerein and its metabolite have been shown in vitro and in
vivo models to be primarily due to potent inhibition of the
productionandactivityofinﬂammatorycytokinesandother
catabolic cytokines expressed in OA, which are involved in
cartilage catabolism and also may induce the apoptosis of
chondrocytes [18, 19]. In addition to anticatabolic eﬀect,
their anabolic properties are also demonstrated [20, 21].
Both diacerein and rhein stimulate production of carti-
lage growth factors such as transforming-growth-factor-beta
(TGF-beta) [20, 21]. This factor stimulates chondrocyte pro-
liferationandconsequentlyincreasessynthesisofthecompo-
nents of cartilage, such as collagen and proteoglycan. Several
randomized controlled trials have demonstrated beneﬁcial
roleofdiacereininkneeandhipOA[22],withpain-relieving
actionstartingaround4weeksoftherapythatstillpersistsfor
1-2 months after discontinuation, indicating possible “carry-
over” eﬀect [23]. Recent meta-analyses have found diacerein
to be signiﬁcantly superior to placebo and comparable to
NSAIDs but with better tolerability proﬁle [24].
2.MaterialsandMethods
2.1. Animal. Three-month-old, male New Zealand White
rabbits (2.5–3.0kg, National Laboratory Animal Center,
Thailand) were used in this study. All animals were housed
individually and allowed unlimited activity and free access to
water and food. This experiment has been permitted by the
Ethics Committee for Experimental Animals of Khon Kaen
University, Thailand (AE 006/53).
2.2. Surgical Technique. Each rabbit was pretreated with
intramuscular oxytetracycline (General Drug House Co.
Ltd., 20mg/kg), and the rabbit was fasted for 12–18 hours
prior to the operation. The animals were anesthetized with
intramuscular injection of ketamine (Calypsol, 15mg/kg),
xylazine (L.B.S Laboratory Ltd. Part., 5mg/kg), and acepro-
mazine (Phoenix Pharmaceutical, 1mg/kg). Both knee joints
were approached through an anterior medial parapatellar
longitudinal incision under sterile conditions. Full-thickness
articular defects (FTDs) were created as described by Mess-
ner[25]withsomemodiﬁcations.Inbrief,theapproximately
rectangular (5mm × 10mm) defect was performed along
the patellar groove of the femoral condyle with a curette
without violating the subchondral bone. Only in the left
knee, subchondral drillings were introduced to the defect
by using a small drill bit (Chondropick). Four drill holes
were made in a row inside the bare subchondral area. The
operative ﬁeld was irrigated clean, and the wound was then
closedinlayers.Bleedingwasnotactivewhilemakingsutures
and therefore neither drainage system nor external com-
pression was required. Oxytetracycline (20mg/kg) was given
intramuscularly for 6 days, and the stitches were removed on
day 7.
2.3. Experimental Procedures. A week after the operation, the
rabbits were randomly allocated to three groups, 10 of each,
receiving: (1) IA injection of normal saline solution (NSS)
+ daily oral NSS; (2) IA injection of HA + daily oral NSS;
(3) IA injection of HA + daily oral diacerein. The NSS used
in group (1) was expected to have only placebo eﬀect and
was considered a control, whereas in group (2) and (3), each
animal received IA injection of 0.3mL (10mg/mL) of HA
(Ostenil, Chemedica, Germany, MW of 2 × 106 Da) once a
week for 5 consecutive weeks into both knees. For group (3),
daily oral administration of diacerein (3.5mg/KgBW/day)
was added to a course of ﬁve IA injections of HA and
continued until the end of the experiment.
2.4. Tissue Processing and Histological Evaluation. 10 weeks
after operation, the animals were sacriﬁced and the operated
knees were harvested. Repaired tissue was assessed blindly
by three investigators both macroscopically and microscop-
ically. After gross assessment, the specimens were prepared
a n dﬁ x e di n1 0 %( v / v )b u ﬀered formalin, decalciﬁed with
10% EDTA/TRIS-HCl (pH 7.4), dehydrated with a series of
graded alcohol, and embedded in paraﬃn. Tissue sections
(6μm thick) were stained with Haematoxylin-Eosin (H&E)
for morphologic analysis. The type and healing potential
of the tissue were assessed by Dorotka’s criteria (Table 1)
[14] and International Cartilage Repair Society (ICRS) score
(Table 2)[ 15], respectively. Cell proliferation was accounted
by measuring proliferating cell nuclear antigen (PCNA,
Dako, USA), and collagen type (Collagen I Ab (ab6308),
Abcam, USA; Collagen II Ab-2 (Clone 2B1.5), Neo-markers,The Scientiﬁc World Journal 3
Table 1: Histological criteria used to demonstrate tissue types
(Dorotka’s criteria) [14].
Tissue type Histologic criteria
Fibrous tissue
(i) Highly orientated type I collagen ﬁbrous
structure
(ii) Cells with elongated shape, not in lacunae
Hyaline
cartilage
(i) Ground glass-like appearance of the matrix
(ii) Type II collagen staining (with variable
intensity of the latter)
(iii) Spherical chondrocytes in mature lacunae
Fibrocartilage
(i) Encompassed a wide range of tissues between
ﬁbrous tissue and hyaline cartilage, including
ﬁbrocartilage
(ii) Oval and spherical cell shapes with and
without lacunae
(iii) Varying intensity of staining for
proteoglycans and type I and II collagen
(iv) No hyaline appearance of the matrix
Articular
cartilage
(i) Hyaline cartilage with columnar arrangement
of the cells
(ii) Matrix staining typical of articular cartilage
USA) was determined using immunohistochemical stain-
ing. In brief, immunohistochemistry was performed on
rehydrated 6μm thick sections using antibodies to PCNA
(dilution 1:400), type I collagen (dilution 1:200), and type
II collagen (dilution 1: 100). The antigen retrieval was
digested with pepsin (Dako, USA) at 1mg/mL Tris-HCl, pH
2.0 for 15min at room temperature in case of collagen I
and collagen II. Envision and system-HRP-labeled polymer
(Dako, USA) were used to locate immunoreactivity with
DAB as chromogen. Contrast staining with hematoxylin was
performed followed by dehydration, mounting, and qualita-
tive light microscopic evaluation.
2.5. Statistical Analysis. Histological scores were assessed for
their normality and equal variance assumptions of paramet-
ric statistics. If the data satisﬁed these assumptions, one-way
analysis of variance (ANOVA) was used to compare means
of histological scores among treatment groups. If the F-test
was signiﬁcant (P<0.05), then the Scheﬀe test for multiple
comparisons was used to ﬁnd out which pairs of treatment
groups were signiﬁcantly diﬀerent. If the data violated the
assumptions, they were analyzed by the Kruskal-Willis test
and Mann Whitney test. The data were expressed as mean ±
standard error of means (SEM). Diﬀerences were considered
signiﬁcantifP<0.05. Allstatisticaltestswerepreparedusing
SPSS (version 17, SPSS, Inc, Chicago).
3. Results
None of the animals showed any evidence of infections or
allergic reactions from IA injection of HA.
3.1.MorphologicalandHistologicalCharacteristicsofFTDand
SCD in Rabbit Knees. Gross, H&E stained, and collagen type
histology from the regenerated cartilaginous tissue after FTD
and SCD creation were evaluated (Figure 1).
Table 2: ICRS Visual Histological Assessment Scale (modiﬁed by
Mainil-Varlet, 2003) [15].
Feature Score
H&E
(I) Surface
Smooth/continuous 3
Discontinuities/irregularities 0
(II) Matrix
Hyaline 3
Mixture: hyaline/ﬁbrocartilage 2
Fibrocartilage 1
Fibrous tissue 0
(III) Cell distribution
Columnar 3
Mixed/columnar clusters 2
Clusters 1
Individual cells/disorganized 0
(IV) Cell population viability
Predominantly viable 3
Partially viable 1
<10% viable 0
(V) Subchondral bone
Normal 3
Increased remodeling 2
Bone necrosis/granulation tissue 1
Detached/fracture/callus at base 0
(VI) Cartilage mineralization (calciﬁed cartilage)
Normal 3
Abnormal/inappropriate location 0
PCNA
Positive 3
Negative 0
Collagen type I
Abundant 3
Little 1
No 0
Collagen type II
Abundant 3
Little 1
No 0
3.1.1. Gross Morphology. Normal articular cartilage from the
rabbit knee aged 3-4 months appeared white, clear, and
glistening (Figure 1(a)). After 10 weeks of surgical operation,
gross evaluation of the repaired tissue demonstrated that
the FTD site appeared dull and pale-yellowish (Figure 1(b)),
while the drilling holes within the FTD lesion contained new
cartilaginous tissue ﬁlling up the lesions (Figure 1(c)).
3.1.2. Histological Characteristics
H&E Staining. The histology of normal articular cartilage
shows the horizontal lining of superﬁcial chondrocytes along4 The Scientiﬁc World Journal
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Figure 1: Gross morphology, H&E-stained, and immunohistochemical stained sections of normal (left panel), FTD (middle panel), and
FTD plus SCD (right panel) 10 weeks after operation (Col I: collagen I; Col II: collagen II; NSS: normal saline solution; HA: hyaluronic acid;
DC: diacerein).The Scientiﬁc World Journal 5
Full-thickness defect  (FTD) 
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Figure 2: The histological sections of femoral condyle stained with H&E 10 weeks after operation. The sections showed the repaired tissue
treated with HA + NSS (c, d) and HA + diacerein (e, f) compared with the control (a, b) (NSS: normal saline solution; HA: hyaluronic acid;
DC: diacerein).6 The Scientiﬁc World Journal
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Figure 3: Eﬀect of HA + NSS and HA + DC on ICRS scores for
the cartilaginous tissue regeneration of FTD (white bar) and SCD
(black bar) 10 weeks after operation. Each value represents the
mean ± SEM, n = 10. ∗P<0.05, ∗∗P<0.001 signiﬁcantly diﬀerent
from control; #P<0.05 signiﬁcant diﬀerence between two groups.
(NSS: normal saline solution; HA: hyaluronic acid; DC: diacerein;
ICRS: International Cartilage Repair Society; SCD: subchondral
drilling; FTD: full-thickness articular defects).
with the articular surface and aligned as vertical columns in
deeper zone (Figure 1(d)). According to Dorotka’s criteria
(Table 1)[ 14], the repaired tissue showed ﬁbrosis in the FTD
lesion (Figure 1(e)), while the SCD induced ﬁbrocartilage
formation (Figure 1(f)).
Collagen Type. Immunohistochemistry revealed more in-
t e n s et y p eIc o l l a g e ni nF T Da r e a( Figure 1(h))c o m p a r e d
to SCD (Figure 1(i)) and normal cartilage (Figure 1(g)). In
contrast, intensity of type II collagen was found mostly in
normal cartilage (Figure 1(j)), which was more than that of
FTD (Figure 1(k))a n dS C Da r e a s( Figure 1(l)). These ﬁnd-
ingsconﬁrmtheﬁbrosisandﬁbrocartilageformationinFTD
and SCD lesions.
3.2. Result of Intraarticular Injection of HA with or
without Oral Administration of Diacerein 10 Weeks
Following Operation
3.2.1. Histological Analysis. 10 weeks after the operation, his-
tological analyses indicated that the quality of the regener-
ated tissues diﬀered in each group.
H&E Staining. H&E staining showed the cartilaginous tissue
regenerated markedly in knees with SCD (Figures 2(b), 2(d),
and 2(f)) as compared with FTD (Figures 2(a), 2(c),a n d
2(e)).Furthermore,therepairedtissueinSCDoftheanimals
t r e a t e dw i t hH A+N S S( Figure 2(d)) or HA + diacerein
(Figure 2(f)) was thicker than the control (Figure 2(b)).
Using a modiﬁed component of the International Car-
tilage Repair Society (ICRS) visual histological assessment
scale (Table 2)[ 15], the mean ICRS score for repaired tissue
gradingoftheFTDtreatedwithHA+NSSorHA+diacerein
(8.67 ± 0.91 and 6.62 ± 0.64, resp.) was not signiﬁcantly
diﬀerent from the NSS group (7.67 ± 0.99), while statistical
diﬀerence was seen in the knees with SCD treated with HA +
NSS or HA + diacerein (13.21 ± 0.55, P = 0.012 and
14.6 ± 0.33, P<0.001; resp.). Furthermore, HA + diacerein
treatment resulted in higher ICRS score compared to HA +
NSS treatment (P = 0.028) (Figure 3).
Analysis using Dorotka’s criteria (Table 1) showed that
HA + NSS and HA + diacerein treatmentsalso aﬀectedtissue
type ofthe regeneratedcartilage.Theanimal knees withFTD
treated with HA + NSS and HA + diacerein showed decrease
ofﬁbroustissueandﬁbrocartilagecomparedwiththecontrol
group, while increase of hyaline type was seen in knees with
SCD in HA + NSS and HA + diacerein groups (Figure 4).
It is notable that hyaline cartilage formation was observed
only in HA + diacerein group. Furthermore, HA + NSS and
HA + diacerein treatments also aﬀected cell proliferation
(Figure 5).
PCNA Staining. Using PCNA staining (Figure 5), cell pro-
liferation was induced in SCD and signiﬁcantly increased in
both HA + NSS- and HA + diacerein-treated animals. Cell
proliferation in FTD group was also induced with both treat-
ments. It is noticeable that cell proliferation in both FTD and
SCD groups treated with HA + diacerein was signiﬁcantly
higher than that in the group with HA + NSS treatment.
Collagen Type. Using immunohistochemical staining, there
was no diﬀerence for type I collagen content in animals
t r e a t e dw i t hH A+N S So rH A+d i a c e r e i na sc o m p a r e dw i t h
the controls in knees both with FTD and SCD (Figure 6).
ThemagnitudeoftypeIIcollagencontentforbothtreatment
groups was also not diﬀerent in FTD, while after SCD, the
content was signiﬁcantly increased in HA + NSS and HA +
diacerein treatment groups (P = 0.038 and P<0.001, resp.)
(Figure 7). It was noted that HA + diacerein-treated group
contained signiﬁcantly higher amount of type II collagen
than that treated with HA + NSS (P = 0.039).
4. Discussion
Friabilityandmechanicalweaknessoftheﬁbrocartilagechal-
lenge the search of more appropriate substance to modify the
quality of the cartilaginous healing. In this experiment, HA
with or without diacerein was chosen. Using a modiﬁed
component of the ICRS cartilage repair assessment scoring
scale (Table 2), both HA + NSS and HA + diacerein did not
stimulate chondral regeneration in FTD (Figure 3)a sh a d
been reported by Evanich [26]. Immunohistochemical stain-
ing also showed no diﬀerence in both types of collagen con-
tents from FTD in animals treated with HA + NSS or HA +
diacerein (Figures 6 and 7). On the contrary, cell prolifer-
ation was signiﬁcantly enhanced by both HA + NSS and
HA + diacerein treatments demonstrated by PCNA staining
(Figure 5). In addition, cell proliferation in HA + diacerein-
treated group was signiﬁcantly increased compared with the
control (P<0.001) or with HA + NSS treatment only (P =
0.025). This result suggests that diacerein could promote
cell proliferation more than that resulted from HA +
NSS treatment. An anabolic eﬀect of diacerein has been
conﬁrmed in previous studies [21].The Scientiﬁc World Journal 7
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Figure 4: The mean score of the sections of repair cartilage varied according to morphology. Bars represent standard error of the mean
(SEM) (NSS: normal saline solution; HA: hyaluronic acid; DC: diacerein; SCD: subchondral drilling; FTD: full-thickness articular defects).
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Figure 5: Eﬀe c to fH A+N S Sa n dH A+D Co nc e l lp r o l i f e r a t i o n ,
using PCNA staining, 10 weeks after operation. Each value repre-
sents the mean ± SEM, n = 10. ∗P<0.05, ∗∗P<0.001 signiﬁcantly
diﬀerent from control; #P<0.05 signiﬁcant diﬀerence between
two groups (NSS: normal saline solution; HA: hyaluronic acid; DC:
diacerein; SCD: subchondral drilling; FTD: full-thickness articular
defects).
In SCD group, HA + NSS treatment stimulated larg-
er amount of cartilaginous tissue ﬁlling in the holes
(Figure 2(d)). The tissue was more hyalinelike and contained
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Figure 6: Eﬀe c to fH A+N S Sa n dH A+D Co nt y p eIc o l l a g e n
10 weeks after operation. Each value represents the mean ± SEM,
n = 10 (NSS: normal saline solution; HA: hyaluronic acid; DC:
diacerein; SCD: subchondral drilling; FTD: full-thickness articular
defects).
higher type II collagen content (Figure 7). These results
agree with those of Karna et al. who suggested that HA
might facilitate prolidase function in collagen biosynthesis
[27]. The potential of HA in the repair of injured articular8 The Scientiﬁc World Journal
0
1
2
3
4
NSS NSS
SCD FTD
C
o
l
 
I
I
-
s
t
a
i
n
e
d
 
s
c
o
r
e
#
∗∗
∗
HA + NSS HA + DC HA + NSS HA + DC
Figure 7: Eﬀect of HA + NSS and HA + DC on type II collagen 10
weeks after operation. Each value represents the mean ± SEM, n =
10. ∗P<0.05, ∗∗P<0.001signiﬁcantlydiﬀerent from control; #P<
0.05 signiﬁcant diﬀerence between two groups (NSS: normal saline
solution; HA: hyaluronic acid; DC: diacerein; SCD: subchondral
drilling; FTD: full-thickness articular defects).
cartilagemaybepartlyaccountedbyrecruitingchondrogenic
cells and promoting migration of chondrocytes in the
cartilaginous tissue. This ﬁnding was also supported by
Chung and colleagues [28] by measuring the early gene
expression and production of cartilage-speciﬁc matrix pro-
teins. Chondrogenesis has been demonstrated in the culture
of mesenchymal stem cells (MSCs) in HA hydrogels [29].
MSCs are multipotent progenitor cells released from bone
marrow during the drilling procedure and have the ability
to diﬀerentiate into several cell types, including chondro-
cytes. Besides MSCs, microfracture also introduces access of
many growth factors, such as transforming-growth-factor-
β1( T G F - β1) and b-FGF, into the joint [30]. These growth
factors would then help transform MSCs into chondrocytes
and increase chondrocyte proliferation.
The present study also demonstrates the additive eﬀectof
diacerein to HA. Signiﬁcant tissue proliferation, conﬁrmed
by the ICRS score (Figure 3) and PCNA staining (Figure 5),
was seen at the drilled holes as compared with NSS and HA
treatmentalone. Theadditive eﬀectofdiacereintoHAmight
work through production of cartilage growth factors such as
TGF-β [20]. This factor stimulates chondrocyte proliferation
and consequently increases synthesis of components of the
cartilage,suchascollagen.Inaddition,ananticatabolic eﬀect
of diacerein has also been reported. Both diacerein and its
active metabolite, rhein, are powerful inhibitors of inﬂam-
matory cytokines, such as IL-1 [31], nitric oxide [18], and
metalloproteases (collagenase and stromelysin) [19, 32] that
are involved in cartilage degradation. Furthermore, both
diacerein and rhein reduce the sensitivity of chondrocytes
to IL-1 by reducing IL-1 receptor levels on the cell surface
and indirectly increase production of IL-1ra (the natu-
ral inhibitor of IL-1receptor binding) in human cartilage
throughdecreasedNOproduction[18].ByinhibitingtheIL-
1 converting enzyme (ICE) production, diacerein and rhein
reduce the production of active IL-1 [33].
In conclusion, our ﬁndings suggest that ﬁve successive
weekly IA injections of HA a week after SCD stimulates
chondrocyte division and increases type II collagen content.
Furthermore, adding diacerein to HA can enhance chon-
droprotective eﬀect of HA. We believe that this procedure is
feasible to improve properties of the regenerated ﬁbrocarti-
lage,asaresultofordinaryhealingprocess,toaqualitycloser
tothatofhyalinecartilage.Thisﬁndingopensanewprospect
of combining HA and diacerein to SCD, or comparably
microfracture, as a treatment of FTD in the human joint.
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